Clarke JM - Search Results

1

Molecular Landscape of BRAF-Mutant NSCLC Reveals an Association Between Clonality and Driver Mutations and Identifies Targetable Non-V600 Driver Mutations.

Negrao MV, Raymond VM, Lanman RB, Robichaux JP, He J, Nilsson MB, Ng PKS, Amador BE, Roarty EB, Nagy RJ, Banks KC, Zhu VW, Ng C, Chae YK, Clarke JM, Crawford JA, Meric-Bernstam F, Ignatius Ou SH, Gandara DR, Heymach JV, Bivona TG, McCoach CE. Negrao MV, et al. Among authors: clarke jm. J Thorac Oncol. 2020 Oct;15(10):1611-1623. doi: 10.1016/j.jtho.2020.05.021. Epub 2020 Jun 13. J Thorac Oncol. 2020. PMID: 32540409 Free PMC article.

2

Immune Activation in Early-Stage Non-Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab.

Yi JS, Ready N, Healy P, Dumbauld C, Osborne R, Berry M, Shoemaker D, Clarke J, Crawford J, Tong B, Harpole D, D'Amico TA, McSherry F, Dunphy F, McCall SJ, Christensen JD, Wang X, Weinhold KJ. Yi JS, et al. Clin Cancer Res. 2017 Dec 15;23(24):7474-7482. doi: 10.1158/1078-0432.CCR-17-2005. Epub 2017 Sep 26. Clin Cancer Res. 2017. PMID: 28951518 Free PMC article. Clinical Trial.

3

Therapeutic outcomes in non-small cell lung cancer with BRAF mutations: a single institution, retrospective cohort study.

Tan I, Stinchcombe TE, Ready NE, Crawford J, Datto MB, Nagy RJ, Lanman RB, Gu L, Clarke JM. Tan I, et al. Among authors: clarke jm. Transl Lung Cancer Res. 2019 Jun;8(3):258-267. doi: 10.21037/tlcr.2019.04.03. Transl Lung Cancer Res. 2019. PMID: 31367539 Free PMC article.

4

Definitive Radiotherapy for Inoperable Stage IIB Non-small-cell Lung Cancer: Patterns of Care and Comparative Effectiveness.

Jacobs CD, Gao J, Wang X, Clarke JM, Tong B, Ready NE, Suneja G, Kelsey CR, Torok JA. Jacobs CD, et al. Among authors: clarke jm. Clin Lung Cancer. 2020 May;21(3):238-246. doi: 10.1016/j.cllc.2019.10.005. Epub 2019 Oct 19. Clin Lung Cancer. 2020. PMID: 31757764 Free PMC article.

5

RNA splicing and aggregate gene expression differences in lung squamous cell carcinoma between patients of West African and European ancestry.

Deveaux AE, Allen TA, Al Abo M, Qin X, Zhang D, Patierno BM, Gu L, Gray JE, Pecot CV, Dressman HK, McCall SJ, Kittles RA, Hyslop T, Owzar K, Crawford J, Patierno SR, Clarke JM, Freedman JA. Deveaux AE, et al. Among authors: clarke jm. Lung Cancer. 2021 Mar;153:90-98. doi: 10.1016/j.lungcan.2021.01.015. Epub 2021 Jan 14. Lung Cancer. 2021. PMID: 33465699 Free PMC article.

6

Predictive Value of Combining Biomarkers for Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors.

Kao C, Powers E, Wu Y, Datto MB, Green MF, Strickler JH, Ready NE, Zhang T, Clarke JM. Kao C, et al. Among authors: clarke jm. Clin Lung Cancer. 2021 Nov;22(6):500-509. doi: 10.1016/j.cllc.2021.03.017. Epub 2021 Mar 27. Clin Lung Cancer. 2021. PMID: 33972172 Free article.

7

Poziotinib in Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutations After Prior Therapies: ZENITH20-2 Trial.

Le X, Cornelissen R, Garassino M, Clarke JM, Tchekmedyian N, Goldman JW, Leu SY, Bhat G, Lebel F, Heymach JV, Socinski MA. Le X, et al. Among authors: clarke jm. J Clin Oncol. 2022 Mar 1;40(7):710-718. doi: 10.1200/JCO.21.01323. Epub 2021 Nov 29. J Clin Oncol. 2022. PMID: 34843401 Free PMC article. Clinical Trial.

8

Use of Low-Frequency Driver Mutations Detected by Cell-Free Circulating Tumor DNA to Guide Targeted Therapy in Non-Small-Cell Lung Cancer: A Multicenter Case Series.

Jacobs MT, Mohindra NA, Shantzer L, Chen IL, Phull H, Mitchell W, Raymond VM, Banks KC, Nagy RJ, Lanman RB, Christensen J, Patel JD, Clarke J, Patel SP. Jacobs MT, et al. JCO Precis Oncol. 2018 Nov;2:1-10. doi: 10.1200/PO.17.00318. JCO Precis Oncol. 2018. PMID: 35135131

9

A Phase 2 Clinical Trial of Combination Nivolumab, Ipilimumab, and Paclitaxel in Patients With Untreated Metastatic NSCLC: The OPTIMAL Trial.

Clarke JM, Gu L, Wang XF, Stinchcombe TE, Stevenson MM, Ramalingam S, Shariff A, Garst J, Nixon AB, Antonia SJ, Crawford J, Ready NE. Clarke JM, et al. JTO Clin Res Rep. 2022 May 17;3(6):100337. doi: 10.1016/j.jtocrr.2022.100337. eCollection 2022 Jun. JTO Clin Res Rep. 2022. PMID: 35719867 Free PMC article.

10

Patient-Reported Distress and Clinical Outcomes with Immuno-Oncology Agents in Metastatic Non-Small Cell Lung Cancer (mNSCLC): A Real-World Retrospective Cohort Study.

Bodd MH, Locke SC, Wolf SP, Antonia S, Crawford J, Hartman J, Herring KW, Ready NE, Stinchcombe TE, Troy JD, Williams C, Clarke JM, LeBlanc TW. Bodd MH, et al. Among authors: clarke jm. Lung Cancer. 2023 Jan;175:17-26. doi: 10.1016/j.lungcan.2022.11.010. Epub 2022 Nov 21. Lung Cancer. 2023. PMID: 36442383

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

336 results

Search Page